COVID-19 Vaccine: Latest News on COVID-19 Vaccine, COVID-19 Vaccine Photos

COVID-19 Vaccine

Prime Minister Narendra Modi chairs a high-level meeting to review the planning and preparations for vaccination against COVID-19, through video conferencing, in New Delhi.

PIB/PTI Photo
A lab technician extracts a portion of a COVID-19 vaccine candidate during testing at the Chula Vaccine Research Center, run by Chulalongkorn University in Bangkok, Thailand. Resea...

Photo by AP/PTI
Prime Minister Narendra Modi chairs a meeting of the task force on Coronavirus vaccine development, in New Delhi. PM also took a detailed review of the current status of India’s ...

PTI Photo

more>>>

Website

COVID-19: DCGI Gives Nod To Indian Institute For Phase 2 And 3 Human Clinical Trials Of Oxford Vaccine Candidate

As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29.

Aug 03, 2020

| PTI
UK Strikes Pact For 60 Million Doses Of Experimental Covid-19 Vaccine

The agreement with Britain's GSK and France's Sanofi will supply the UK with 60 million doses of their vaccine based on existing DNA-based technology used to produce Sanofi’s flu vaccine.

Jul 29, 2020

| PTI
Moderna’s Covid-19 Vaccine Induces Robust Immune Response In Monkeys

The candidate vaccine, mRNA-1273, has been co-developed by scientists at Moderna and the National Institute of Allergy and Infectious Diseases in the US.

Jul 29, 2020

| PTI
Five Sites Ready For Final Phase Of Oxford-AstraZeneca COVID-19 Vaccine Trials In India: Govt

The Serum Institute of India, the largest vaccine maker in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it is ready.

Jul 28, 2020

| PTI
Increase Daily COVID-19 Testing Capacity To 1 Lakh: UP CM Yogi Adityanath To Officials

The Uttar Pradesh CM also stressed the need to increase the number of tests in a phased manner for which 10 lakh testing kits should be acquired every 10 day.

Jul 25, 2020

| PTI
Serum Institute Of India Seeks DCGI Nod For Phase 2/3 Clinical Trials Of Oxford's COVID Vaccine: Report

Serum Institute of India CEO Adar Poonawalla said it has entered a manufacturing partnership with AstraZeneca to produce and supply 1 billion doses of the COVID-19 vaccine.

Jul 25, 2020

| PTI
Scientists Decode How Coronavirus Is Mutating, Say Findings May Aid Vaccine Development

In the case of the novel coronavirus SARS-CoV-2, the study, published in the journal Molecular Biology and Evolution, noted that the process may not be random, and that humans are mutating it as part of a defence mechanism to degrade the virus.

Jul 23, 2020

| PTI
2 Chinese Hackers Targeted Covid-19 Research, American Companies: US

The hackers, identified as Li Xiaoyu and Dong Jiazhi, stole information not only for their personal profit but also research and technology that they knew would be of value to the Chinese government, prosecutors say.

Jul 22, 2020

| Associated Press (AP)
'Will Leave No Stone Unturned': India To Ensure Regulatory Facilitation For Trial Of Covid Vaccine

With the trials of COVID-19 vaccine being developed by AstraZeneca and Oxford University showing encouraging results, the Serum Institute of India (SII) has said it will apply for license from the Indian regulator to start clinical trials of the shot in a week's time.

Jul 22, 2020

| PTI
WHO Hails 'Good News' From Early Trials Of Oxford Covid-19 Vaccine

A WHO official noted that there are 23 COVID-19 candidate vaccines in clinical development, but until Monday only one had produced Phase 1 clinical data.

Jul 21, 2020

| Associated Press (AP)